22,23-dihydroavermectin b1 , ivermectin , derived from avermectin b1 by selective hydrogenation using wilkinson 's homogenous catalyst [ ph3p ) 3rhcl ] , was shown to be a highly effective drug for the treatment of a wide variety of metazoan parasitic diseases in animals .
C0022322
ivermectin
C0003404
drug for